The price of Braskem S.A. ADR (NYSE: BAK) closed at $8.47 in the last session, up 2.17% from day before closing price of $8.29. In other words, the price has increased by $+0.18 from its previous closing price. On the day, 865132 shares were traded.
Ratios:
We take a closer look at BAK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.54. In the meantime, Its Debt-to-Equity ratio is 11.44 whereas as Long-Term Debt/Eq ratio is at 10.77.
On July 05, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $11.50 to $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 3.37B and an Enterprise Value of 11.75B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.10 while its Price-to-Book (P/B) ratio in mrq is 3.36. Its current Enterprise Value per Revenue stands at 0.16 whereas that against EBITDA is 3.58.
Stock Price History:
Over the past 52 weeks, BAK has reached a high of $12.67, while it has fallen to a 52-week low of $6.26. The 50-Day Moving Average of the stock is 7.79, while the 200-Day Moving Average is calculated to be 8.76.
Shares Statistics:
According to the various share statistics, BAK traded on average about 1.16M shares per day over the past 3-months and 1.24M shares per day over the past 10 days. A total of 172.20M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of Feb 15, 2024 were 2.36M with a Short Ratio of 2.20, compared to 2.27M on Jan 12, 2024.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.55 for the current quarter, with a high estimate of -$0.55 and a low estimate of -$0.55, while EPS last year was -$0.81. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$2.16 and -$2.16 for the fiscal current year, implying an average EPS of -$2.16. EPS for the following year is -$0.98, with 1 analysts recommending between -$0.98 and -$0.98.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $14.03B, while the lowest revenue estimate was $14.03B, resulting in an average revenue estimate of $14.03B. In the same quarter a year ago, actual revenue was $18.7B, down -25.00% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $14.39B in the next fiscal year. The high estimate is $14.39B and the low estimate is $14.39B. The average revenue growth estimate for next year is up 2.60% from the average revenue estimate for this year.
